GlassScriptPhysician profile
Maria Litzendorf
NPI 1598935058
$51,427.43
in general payments reported to CMS, 2019-2025
31 companies · $10K in 2025
The $10K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $350 · 2021: $939 · 2022: $5,264 · 2023: $16K · 2024: $18K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $40K · Food and Beverage: $4,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $39,883.33 |
| Food and Beverage | $4,844.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $44,490.38 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Endologix LLC | $2,958.32 | 2020-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Medtronic, INC. | $559.61 | 2022-2025 | Heli-Fx Endoanchor System, Venaseal, Endurant Iis |
| W. L. Gore & Associates, INC. | $501.87 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Avinger INC. | $467.13 | 2021 | |
| Janssen Pharmaceuticals, INC | $363.30 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $310.31 | 2022-2025 | Eliquis |
| Lemaitre Vascular, INC. | $275.20 | 2022-2025 | Restoreflow, Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Boston Scientific Corporation | $265.22 | 2021-2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Tactile Systems Technology INC | $219.85 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Acera Surgical, INC. | $156.75 | 2019-2020 | |
| Philips North America LLC | $120.84 | 2022-2023 | |
| Abbott Laboratories | $109.98 | 2021 | |
| Janssen Scientific Affairs, LLC | $92.95 | 2022 | |
| Mimedx Group, INC. | $67.68 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $67.44 | 2020-2023 | Advance |
| Cordis US Corp. | $52.19 | 2024 | Radial 360, Rain Sheath, Mynx Control |
| Bard Peripheral Vascular, INC. | $50.01 | 2020 | |
| Asahi Intecc USA, INC. | $42.28 | 2025 | Asahi Peripheral Vascular Wires |
| Smith+Nephew, INC. | $35.11 | 2020-2022 | |
| Convatec INC. | $33.02 | 2025 | |
| Veryan Medical Incorporated | $25.43 | 2021 | |
| Amgen INC. | $23.10 | 2025 | Repatha |
| Cardiovascular Systems INC. | $22.92 | 2020 | |
| Shockwave Medical, INC | $20.72 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Koya Medical, INC. | $20.58 | 2025 | Koya Medical, Dayspring |
| Organogenesis INC. | $18.25 | 2024 | |
| Silk Road Medical, INC. | $16.56 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Biocompatibles, INC. | $16.04 | 2019 | |
| Reprise Biomedical, INC. | $15.74 | 2023 | Miro3d Fibers, Miroflex, Miro3d |
| Reflow Medical INC | $8.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Litzendorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.